Products
Search and purchase from millions of reagents, consumables and lab supplies listed all in one place.
We connect researchers and suppliers working with data and evidence to guide value-based decisions
The fields of Health Economics and Outcomes Research (HEOR), Real World Evidence (RWE) and Market Access, collectively referred to as Medical/Commercial within the pharmaceutical industry, are at the heart of this transformation due to the pivotal role they play in payer reimbursement, post-marketing safety surveillance and patient outcomes assessment within and outside randomized clinical trials.
As this need becomes increasingly vital, complex and multi-dimensional, it is imperative to find sourcing and procurement solutions that speed up delivery of commercially-relevant evidence.
Scientist.com supports the outsourcing of Medical/Commercial projects by helping buyers and sellers of these services establish external partnerships to address the critical business need, workload, regulatory pressures and talent gap, while improving the values of medicines available to patients across the globe.
The HEOR services market is expected to nearly double in size from $1.75B to $3.29B in the next 5 years[1]
Biopharma accounted for 56.11% share of HEOR services market size in 2024[1]
The demand for RWE is the #1 industry trend of 2024-25[2]
1Mordor Intelligence. Health Economics And Outcomes Research (HEOR) Services Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
2ISPOR. ISPOR 2024-2025 Top 10 HEOR Trends Report
HealthEconomics.com is the world's largest digital Connected Community™ in the health economic and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) industry. The site provides professionals in this community with a single, digital hub to access industry insights, news, events, market reports and more.
The aim of our HealthEconomics.com is to:
Medical/Commercial services offered on Scientist.com: